Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials.

por Warwick, J., Kehoe, S., Earl, H., Luesley, D., Redman, C., Chan, K. K.
Publicado 1995

Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinoma.

por Kehoe, S., Redman, C., Varma, R., Buxton, J., Luesley, D., Blackledge, G., Stanley, A.
Publicado 1992

Detection of placental-type alkaline phosphatase in ovarian cancer.

por McDicken, I. W., McLaughlin, P. J., Tromans, P. M., Luesley, D. M., Johnson, P. M.
Publicado 1985

Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?

por Redman, C. W., Finn, C., Ward, K., Kelly, K., Buxton, E. J., Varma, R., Shortland-Webb, W., Luesley, D. M.
Publicado 1990

Peritoneal trauma releases CA125?

por Redman, C. W., Jones, S. R., Luesley, D. M., Nicholl, S. E., Kelly, K., Buxton, E. J., Chan, K. K., Blackledge, G. R.
Publicado 1988

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study

por Mesher, D, Szarewski, A, Cadman, L, Cubie, H, Kitchener, H, Luesley, D, Menon, U, Hulman, G, Desai, M, Ho, L, Terry, G, Williams, A, Sasieni, P, Cuzick, J
Publicado 2010